Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Genomic, single-cell, and functional profiling of the CD48-CD244 axis and NK cell dysfunction in multiple myeloma
Bonell Patiño-Escobar, Torsten Steinbrunn, Lucy Perez-Lugo, Sham Rampersaud, Daniel D. Waller, Daniela Ordoñez, Huimin Geng, Fernando Salangsang, Paul Phojanakong, Juan Antonio Camara Serrano, Yan Zeng, Veronica Steri, Oscar A. Aguilar, Constantine S. Mitsiades, Arun P. Wiita
Bonell Patiño-Escobar, Torsten Steinbrunn, Lucy Perez-Lugo, Sham Rampersaud, Daniel D. Waller, Daniela Ordoñez, Huimin Geng, Fernando Salangsang, Paul Phojanakong, Juan Antonio Camara Serrano, Yan Zeng, Veronica Steri, Oscar A. Aguilar, Constantine S. Mitsiades, Arun P. Wiita
View: Text | PDF
Research Article Cell biology Hematology Immunology

Genomic, single-cell, and functional profiling of the CD48-CD244 axis and NK cell dysfunction in multiple myeloma

  • Text
  • PDF
Abstract

Multiple myeloma (MM) orchestrates immune evasion by subverting natural killer (NK) cell function. CD48, one of the most abundant NK ligands on MM cells, paradoxically enhances NK cell activation yet is associated with high-risk cytogenetics and poor patient survival. We integrated multiomics (bulk and single-cell RNA-seq, assay for transposase-accessible chromatin using sequencing [ATAC-seq], chromatin immunoprecipitation sequencing [ChIP-seq]), genome-wide CRISPR knockout/activation screens, and machine learning to dissect CD48 regulation and function. In human MM and Vκ*MYC mouse scRNA-seq datasets, NK cells exhibit stepwise increases in inflammatory and exhaustion signatures and loss of cytotoxic potential as disease progresses. In vitro coculture assays show that CD48 overexpression on MM enhances NK cell cytokine secretion, whereas chronic exposure leads to ex vivo NK dysfunction. In vivo, CD48-overexpressing Vκ*MYC tumors progress more slowly and extend host survival, while NK cell depletion accelerates disease. These findings support a context-dependent role for CD48, potentiating acute NK responses while coexisting with chronic NK exhaustion, and suggest strategies to modulate CD48 for therapeutic benefit.

Authors

Bonell Patiño-Escobar, Torsten Steinbrunn, Lucy Perez-Lugo, Sham Rampersaud, Daniel D. Waller, Daniela Ordoñez, Huimin Geng, Fernando Salangsang, Paul Phojanakong, Juan Antonio Camara Serrano, Yan Zeng, Veronica Steri, Oscar A. Aguilar, Constantine S. Mitsiades, Arun P. Wiita

×

Figure 3

In vitro NK-tumor coculture assays demonstrate CD48-dependent cytokine responses and limited rescue by SHIP1.

Options: View larger image (or click on image) Download as PowerPoint
In vitro NK-tumor coculture assays demonstrate CD48-dependent cytokine r...
(A) Representative flow cytometry intracellular staining for murine IFN-γ, TNF-α, surface CD69, intracellular granzyme B, surface CD244, and surface CD48 after coculture with Vκ*MYC for 24 hours (effector/target 30:1) (representative of n = 3 biological replicates). (B) Percentage target-cell lysis of KIL C.2 against Vκ*MYC WT, CD48KO, and CD48OE across effector/target (E/T) ratios. Points represent mean ± SEM (n = 3 technical replicates). Pairwise Welch’s t tests at each E/T (P values; reported as WT vs. KO / WT vs. OE / KO vs. OE); 30:1 (0.494/0.548/0.954); 10:1 (0.295/0.184/0.077); 3:1 (0.902/0.422/0.413); 1:1 (0.967/0.510/0.183); 1:3 (0.582/0.436/0.613); 1:10 (0.876/0.351/0.373). No pairwise comparison reached P < 0.05. (C) Bar graphs show the percentage of KIL C.2 cells positive for granzyme B, IFN-γ, and TNF-α, measured at E/T = 30:1 (green), E/T = 10:1 (red), or ‘no-Vκ’ PMA/ionomycin control (blue) (n = 3 technical replicates). Pairwise comparisons between Vκ*MYC WT, CD48KO, and CD48OE were performed using 2-tailed t tests with Benjamini-Hochberg correction applied globally across all 18 comparisons. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; absence of asterisks denotes no significant difference (P ≥ 0.05). (D) Flow cytometry histogram showing SHIP1 expression in KIL C.2 cells after CRISPR/Cas9 knockout of the Inpp5d gene (representative of n = 2 technical replicates).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts